ArticleESMO real world data and digital oncology2026
Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol.
F Le Borgne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.